PharmaNet/i3, the inVentiv Health Clinical segment, is providing the first mobile application for bioanalytical assays. The mobile application enables clients to search the company's more than 1000 bioanalytical assays from an iPhone, ...
Tags: Bioanalytical Assays, Mobile Application, PharmaNet/i3, Medicine
Iroko Pharmaceuticals has launched a new corporate headquarters in Philadelphia's Navy Yard Corporate Center, US. The new facility will support increased workforce as the company moves ahead with five late-stage development programs to ...
Tags: drug candidates, drugs, NSAIDs, medications
The Federal Institute for Drugs and Medical Devices, the German regulatory authority, has approved Helix BioPharma's clinical trial application for a European Phase III efficacy trial of Topical Interferon Alpha-2b in patients with ...
Critical Outcome Technologies (COTI) has signed a drug discovery deal with an undisclosed pharmaceutical company to use its CHEMSAS drug discovery system for the identification of small molecules. COTI will look after the discovery, ...
Tags: COTI, new drug research, CHEMSAS
Critical Outcome Technologies has received a patent for its advanced oncology drug candidate, from the US Patent and Trademark Office. The patent covers the synergistic effects of combination therapies containing COTI-2 and members of ...
Tags: oncology drug, COTI-2, anti cancer agents
Aerial BioPharma, a biopharmaceutical company, has won FDA orphan drug designation for its narcolepsy drug in development. The issuance of designation from the FDA follows the completion of a Phase IIa study in which N05 demonstrated ...
Absorption Systems has launched new assay for the human breast cancer resistance protein (BCRP) transporter. The new assay will enable drug developers to test new drug candidates for interactions with BCRP, which is involved in drug ...
Tags: Absorption Systems, breast cancer resistance protein transporter
Galenea and collaborator Kevin Spencer of the VA Boston Healthcare System and Harvard Medical School have won a five year $3m grant from the National Institute of Mental Health (NIMH). The grant is intended for the development of ...
Allergan and Molecular Partners have expanded their existing relationship by entering into two separate agreements to discover, develop and commercialize proprietary therapeutic DARPin products to treat ophthalmic diseases. The first ...
Afraxis and PsychoGenics have formed an alliance to provide Afraxis Enhanced Spine Platform (ESP) technology as part of PsychoGenics comprehensive testing capabilities and drug discovery services. The technology can evaluate as many as ...
Tags: ESP, PsychoGenics, Afraxis
Prosetta Antiviral has entered into a multi-year collaboration with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs. The collaboration will focus on ...
Prosetta Antiviral has entered into a multi-year collaboration with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs. The collaboration will focus on ...
Tags: lect drug candidates, antiviral drugs, viral infections
The University of Washington (UW), University of Texas Medical Branch (UTMB) at Galveston, US, and Kineta have been granted a $8.1m biodefense award by the National Institute of Allergy and Infectious Diseases (NIAID). The funding aims to ...
Tags: the National Institute of Allergy and Infectious Diseases
Pfizer has granted exclusive development and marketing rights to ChemRar group company SatRx for their DPP(1)-IVi compound, PF-00734200 for type 2 diabetes (T2D). T2D is one of the most burdensome chronic non-communicable diseases, which ...
Tags: Satrx Exclusive License, epidemic proportions, R&D portfolio
Sigma-Aldrich's biological products and services business, Sigma Life Science has launched CompoZr Transporter Knockout human cell lines in a consumable, assay-ready plate format. The efflux transporter knockout cell lines identify ...
Tags: Life Science, Transporter Knockout, biological products